The Company was incorporated under the Companies Act, 2013 as a private limited company under the name and style of ÂGloberoute Ventures Private Limited pursuant a certificate of incorporation dated October 26, 2018 issued by the Registrar of Companies, Central Registration Centre. Subsequently, pursuant to resolutions passed by the Board of Directors in their meeting held on December 12, 2020 and by the Shareholders in the ExtraOrdinary General meeting held on December 30, 2020, the name of the Company was changed to ÂFabtech Technologies Private Limited and a fresh certificate of incorporation dated January 21, 2021 was issued by the Registrar of Companies, Maharashtra at Mumbai. The name of the Company was changed to expand the scope of services provided by the Company and for securing better overseas prospects, and to give effect to the order dated November 19, 2020 passed by the National Company Law Tribunal having its bench at Mumbai approving inter alia, demerger of the export division of Fabtech Technologies International Private Limited into the Company. Further, pursuant to resolutions passed by the Board of Directors in their meeting held on March 27, 2024 and by the Shareholders in the Extra-Ordinary General meeting held on April 3, 2024, the Company was converted into a public limited company, consequent to which its name was changed to ÂFabtech Technologies LimitedÂ, and a fresh certificate of incorporation dated July 24, 2024, consequent to such conversion was issued by the Registrar of Companies, Central Processing Centre. Major events and milestones : 2020 - Pursuant to the Scheme of Amalgamation, the export division of FTIPL, under which it executed turnkey pharmaceutical engineering projects, was transferred to the Company. Further, pursuant to the Scheme of Arrangement, the entire shareholding was transferred from FTIPL to the shareholders of FTIPL, by virtue of which, Aasif Ahsan Khan, Hemant Mohan Anavkar Aarif Ahsan Khan and Manisha Hemant Anavkar became the Promoters of the Company. - Crossed Rs. 10,000 lakhs revenue mark in Financial Year 2019-20 2022 - Successfully completed a turnkey project for a state-owned organization in Bangladesh, involving installation of 172 clean room doors across designated buildings, as outlined in the project tender. - Crossed Rs. 25,000 lakhs revenue mark in Financial Year 2021-2022 2023 - Successfully completed supply and installation of process equipment, such as isolators, tablet compression equipment, and related infrastructure of an aggregate value of Rs. 315.94 lakhs for a pharmaceutical manufacturer in Algeria. 2023-2024 - Acquired FT Institutions Private Limited from FTIPL to create a domestic presence and robust government clientele by executing turnkey pharmaceutical engineering projects in India. - With an intent to create a local presence in the Middle Eastern region, set up a wholly-owned subsidiary, Fabtech Technologies LLC and a step-down subsidiary, FTS Cleanrooms Systems LLC in Sharjah, United Arab Emirates. 2024 - Acquired FABL International Technologies LLP from FTIPL to integrate the operations by developing manufacturing capabilities in oral solid dosage process solutions through the Subsidiary. 2025 - Acquired 33.33% stake in Mark Maker Engineering Private Limited, for geographical expansion and operational synergies, thereby making it an associate of the Company. Key awards, accreditations or recognitions : 2017 - Fabtech Technologies International Private Limited (formerly known as Fabtech Technologies International Limited) received a token of appreciation from Bangladesh Milk Producers Co-operative Union Limited. - Fabtech Technologies International Private Limited (formerly known as Fabtech Technologies International Limited) received the title of ÂBrand of the Year, 2017 in recognition for excellence in pharmaceutical and biotechnology by the CEO Magazine. 2021 - The Company received the Tech Leadership Award in the category of Best in future of womenÂs advancement from Kami Kaze. 2022 - Certificate issued by UQSR Global Private Limited declaring that it had assessed the occupational health & safety systems of the Company and had found it to be in conformity with ISO 45001:2018. The scope of activities covered under the certificate were start to finish (turnkey including tech transfer) engineering solution for pharmaceutical, biotech and healthcare industry. - Certificate issued by UQSR Global Private Limited declaring that it had assessed the quality management systems of the Company and had found it to be in conformity with ISO 9001:2015. The scope of activities covered under the certificate were start to finish (turnkey including tech transfer) engineering solution for pharmaceutical, biotech and healthcare industry. 2024 - Accorded the status of two-star export house under the provisions of Foreign Trade Policy, 2023 by the Directorate General of Foreign Trade, Department of Commerce and Ministry of Commerce and Industry. 2025 -Fabtech Technologies announced launch of initial public offering. |
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article